...
机译:相变对比剂的优化靶向MDA-MB-231乳腺癌细胞
Department of Medical Imaging University of Arizona;
Department of Medical Imaging University of Arizona;
Physical Sciences Department Sunnybrook Research Institute;
Joint Department of Biomedical Engineering University of North Carolina and North Carolina State;
Department of Medical Imaging University of Arizona;
Phase-change contrast agents; Nanodroplets; Microbubbles; Targeting agent; Vaporization; Internalization; Ultrasound-mediated activation;
机译:相变对比剂的优化靶向MDA-MB-231乳腺癌细胞
机译:新型C-4杂芳基13-顺式视黄酰胺Mnk / AR降解剂抑制人乳腺癌和前列腺癌细胞的增殖和迁移并诱导其凋亡,并抑制MDA-MB-231人乳腺癌和CWR22Rv1人前列腺肿瘤异种移植物的生长。
机译:岩藻依聚糖提取物增强MDA-MB-231和MCF-7乳腺癌细胞中化学治疗剂的抗癌活性。
机译:超声激活后使用超快速成像立即针对以乳腺癌细胞为目标的相变造影剂的声学响应
机译:白藜芦醇增强了MDA-MB-231和耐紫杉醇的MDA-MB-231乳腺癌细胞中的紫杉醇治疗。
机译:叶酸受体靶向相变造影剂在乳腺癌细胞中的细胞内递送和超声活化
机译:相变造影剂的优化靶向MDA-MB-231乳腺癌细胞
机译:用超快光谱研究目标造影剂与前列腺癌细胞之间的能量转移动力学。